Biopharma Research

Healthy animals are the foundation of a healthy world. As threats to animal health evolve, so do our solutions. At MSD Animal health, we are committed to continuous innovation in biopharma research—not just to treat illness today, but to build a healthier, more resilient future for animals and the people who depend on them.

We are focused on advancing veterinary medicine in key therapeutic areas from combating parasites and infections to improving animal health and performance.

Research

Our industry-leading researchers conduct studies focused on both vaccine and pharmaceutical research, as well as biologics, where we’re focused on using new technologies that will address a range of diseases, including zoonotic diseases that affect both humans and animals. 


With research facilities around the globe, we’re able to respond quickly to local issues and changing market needs.

Development

We aim to be the first when it comes to discovering and developing first- and best-in-class veterinary medicines and vaccines. We have a proven track record in small molecules, vaccine technologies and biotechnologies, such as monoclonal antibodies.

Our robust portfolio of veterinary medicines and vaccines reflects our unwavering commitment to advancing veterinary medicine.

Innovation

We have some ambitious goals when it comes to advancing animal health and we know it will take strategic partnerships to achieve them. That’s why we invest in co-innovation partnerships with pharmaceutical, crop science companies and academic institutions, along with internal discovery efforts.

We also collaborate closely with our colleagues at MSD Human Health to share best practices and leverage the power of our combined research effort.

Featured Stories